Maurice Raymond Verschoyle Finlay

This inventor holds 28 USPTO granted patents and 9 published patent applications, plus 4 CIPO patents and 16 EPO patents, primarily in Cancer Treatment Compounds. Top assignees: Astrazeneca Ab, Cancer Research Technology Limited, Scripps Research Institute. Active years: 2006-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maurice Raymond Verschoyle Finlay. Retrieved from https://idiyas.com/inventor/maurice-raymond-verschoyle-finlay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 9)

% Patents Active = 75.0

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 16 (Patent Applications = 20)

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 76(Granted Patents)

Location History:

Cheshire, GB (2006 - 2015)
Macclesfield, GB (2006 - 2022)
Cambridge, GB (2018 - 2024)

Company Filing History:

Cancer Research Technology Limited

patents

2 out of 1,208

Scripps Research Institute

patents

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

Areas of Expertise:

Arginase Inhibitors

Purinone Compounds

Thiadiazole Compounds

Amino-Triazolopyridine

Bis-Pyridazine

Metalloproteinase Inhibitors

Epothilone Derivatives

Aryl Piperazines

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12435097 - Arginase inhibitors and methods of use thereof (2025-10-07),

2. 12195485 - Arginase inhibitors and methods of use thereof (2025-01-14),

3. 11912727 - Arginase inhibitors and methods of use thereof (2024-02-27),

4. 11884671 - Purinone compounds and their use in treating cancer (2024-01-30),

5. 11753405 - 1,3,4-thiadiazole compounds and their use in treating cancer (2023-09-12),

6. 11746118 - Amino-triazolopyridine compounds and their use in treating cancer (2023-09-05),

7. 11524951 - 2-(2,4,5-substituted-anilino)pyrimidine compounds (2022-12-13),

8. 11420984 - Arginase inhibitors and methods of use thereof (2022-08-23),

9. 11136340 - Amino-triazolopyridine compounds and their use in treating cancer (2021-10-05),

10. 10981904 - 1,3,4-thiadiazole compounds and their use in treating cancer (2021-04-20),

11. 10858336 - 2-(2,4,5-substituted-anilino)pyrimidine compounds (2020-12-08),

12. 10577354 - Bis-pyridazine compounds and their use in treating cancer (2020-03-03),

13. 10407446 - Amino-triazolopyridine compounds and their use in treating cancer (2019-09-10),

14. 10323028 - 1,3,4-thiadiazole compounds and their use in treating cancer (2019-06-18),

15. 10294221 - 1, 3, 4-thiadiazole compounds and their use in treating cancer (2019-05-21),

Title: Trailblazer in Innovation: The Remarkable Journey of Inventor Maurice Raymond Verschoyle Finlay

Introduction:

Maurice Raymond Verschoyle Finlay, a visionary inventor hailing from Cambridge, GB, has made a significant impact in the realm of technology with his relentless pursuit of excellence and passion for innovation. His trailblazing spirit serves as a beacon of inspiration for aspiring inventors worldwide.

Latest Patents:

With an impressive portfolio of 26 patents, Maurice Raymond Verschoyle Finlay continues to push the boundaries of innovation. His latest patents include groundbreaking advancements in the field of medicine and cancer research, such as Arginase inhibitors for treating cancer and a respiratory inflammatory disease, as well as Purinone compounds for treating DNA-PK mediated diseases like cancer.

Career Highlights:

Throughout his illustrious career, Maurice Raymond Verschoyle Finlay has been affiliated with esteemed companies such as AstraZeneca AB and Cancer Research Technology Limited. His expertise and dedication have played a pivotal role in driving forward cutting-edge research and development initiatives within these organizations.

Collaborations:

Collaborating with talented individuals such as Johannes Wilhelmus Maria Nissink and Mark David Charles, Maurice Raymond Verschoyle Finlay has fostered an environment of innovation and excellence. Together, they have worked diligently to bring forth novel solutions to complex medical challenges, leaving a lasting impact on the field of technology and healthcare.

Conclusion:

In conclusion, Maurice Raymond Verschoyle Finlay's remarkable journey as an inventor showcases his unwavering commitment to innovation and his significant contributions to the technological landscape. His pioneering work continues to inspire future generations of inventors to think boldly and strive for greatness in their pursuits of scientific discovery.

Profile summary based on public USPTO records.